Table 1.
Repeated measurement in hemodynamic parameters in baseline, 5th, 15th min, and after study in three studied groups
| Hemodynamic parameters | Baseline | 5th min | 15th min | After study | P |
|---|---|---|---|---|---|
| MAP | |||||
| Dexmedetomidine | 90.48±6.5 | 86.12±7.7 | 98.6±6.8 | 93.96±6.9 | 0.436 |
| Alfentanil | 89.8±6.2 | 84.36±6.9 | 97.54±7.8 | 93.76±6.8 | |
| Control | 90.1±6.3 | 89.52±5.9 | 99.12±6.5 | 92.96±6.4 | |
| HR | |||||
| Dexmedetomidine | 87.20±9.3 | 81.9±8.7 | 95.52±6.7 | 93.28±7.4 | 0.823 |
| Alfentanil | 85.76±10 | 80.28±11.6 | 94.92±8.4 | 93.16±7.8 | |
| Control | 84.32±10.9 | 84.84±12.1 | 95.96±9.5 | 92.24±9.8 | |
| SO2 | |||||
| Dexmedetomidine | 98.96±0.2 | 98.93±0.3 | 97.44±1.4 | 99.1±0.1 | 0.882 |
| Alfentanil | 98.9±0.3 | 98.96±0.2 | 97.24±1.4 | 98.96±0.2 | |
| Control | 99.0±0.12 | 99.12±0.1 | 97.4±1.8 | 98.98±0.1 |
MAP: Mean arterial pressure, HR: Heart rate